← Back to Knowledge Base

Primary topic: CYP3A5 gene steroid hormone processing

CYP3A5 Gene and Metabolism: What It Can Mean in a Pathway Report

CYP3A5 is tracked because it connects to estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context. The current evidence index links this gene to Estrogen metabolism with 1 SNP and 1 curated claim.

What is the CYP3A5 gene?

CYP3A5 is a phase-I CYP3A enzyme that contributes to steroid and xenobiotic metabolism context; staged here as low-impact estrogen-adjacent clearance support.

How CYP3A5 affects metabolism

When CYP3A5-related function is shifted, the practical effect is interpreted through estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context. This does not mean the pathway is active or impaired right now; it means the gene can help prioritize what to check next.

What happens when CYP3A5 is altered

Altered CYP3A5 signal should be treated as a DNA-based tendency, not a diagnosis. 1 claim currently passes the report-use gate. The useful question is whether symptoms, labs, and lifestyle context line up with the pathway signal.

Curated SNP evidence for CYP3A5

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

CYP3A5 currently has 1 curated SNPs, 1 claim-level scores, and 1 claims eligible for pathway scoring.

Open the sample report
rs776746CYP3A5*3 splice allele1 claims · 1 study rows

expression · GG

CYP3A5 functional expression

Strong

rs776746 GG, corresponding to CYP3A5*3/*3, is associated with absent or markedly reduced CYP3A5 functional expression.

CYP3A5 rs776746 is staged as a homozygous CYP3A5*3 no-functional-expression genotype.

Likely effectLower gene expression signal
Signal sizeModerate signal
Evidence supportModerate support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • hormone-context questions that need lab confirmation
  • symptoms that vary with body composition, alcohol, medication, or liver context
  • unexpected SHBG, estradiol, or testosterone patterns

Biomarkers to validate

Estradiol, testosterone, and SHBG

Checks whether hormone balance is actually relevant.

ALT, AST, and GGT

Adds liver clearance context.

Medication and alcohol context

Helps separate genetics from stronger external drivers.

Where DNA analysis helps

DNA helps decide whether CYP3A5 deserves attention inside the broader Estrogen metabolism pathway. It is most useful when combined with biomarkers instead of used as a standalone answer.

Example interpretation

CYP3A5 may add context to estrogen-like hormone clearance, steroid bioavailability, and liver phase-I or phase-Ii context, especially when its SNP evidence lines up with other genes in the same pathway.

Suggested validation: Estradiol, testosterone, and SHBG.

What to do next

  • Review the Estrogen metabolism pathway result before interpreting CYP3A5 on its own.
  • Use relevant biomarkers to confirm whether this DNA tendency is visible in current biology.
  • Treat supplement or nutrition decisions as follow-up steps only after the pattern fits symptoms or labs.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages